CDSCO publishes List of NSQ Pharmaceuticals for December 2023
A total of 1008 samples were tested by the CDSCO. Based on the samples tested, CDSCO has found a total of 78 drugs, medical devices, vaccines and cosmetics that are identified as being not of standard quality.
Restricted Use of iNCOVACC for Booster Vaccination Approved
CDSCO has now also approved ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant COVID19Vaccine (iNCOVACC). This approval is extended to it as a Booster (third) dose vaccination for restricted use in emergencies. This vaccine can be administered intra-nasally.
PAC Applications for Marketing Authorisations for Vaccines & Antisera Now Online
CDSCO launches online system for Post Approval Changes (PAC) with respect to Marketing Authorisations (MAs) for human vaccines and anti-sera.
MoHFW concludes Intensified Mission Indradhanush 5.0, Expanding Immunization Efforts Nationwide
To ensure the campaign’s success, National Monitors conducted Preparedness Assessments from July 19 to July 23, 2023, in 154 high-priority districts spanning 27 States and UTs. Their findings and recommendations were subsequently shared with all the States and UTs involved.
